Reference health

Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases

https://doi.org/10.1038/modpathol.2010.232
CiteStamped reference-health badge
32/32 checkable references clean · checked 2026-08-16

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

7 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 32 checked references that resolve
resolves10.1073/pnas.0405220101
EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib
resolves10.1056/NEJMoa0810699
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
resolves10.1097/PAS.0b013e31815cb162
Lung Adenocarcinoma: Modification of the 2004 WHO Mixed Subtype to Include the Major Histologic Subtype Suggests Correlations Between Papillary and Micropapillary Adenocarcinoma Subtypes, EGFR Mutations and Gene Expression Analysis
resolves10.1002/1097-0142(19950615)75:12<2844::AID-CNCR2820751209>3.0.CO;2-#
Small adenocarcinoma of the lung. Histologic characteristics and prognosis
resolves10.2214/ajr.177.6.1771417
Quantification of Ground-Glass Opacity on High-Resolution CT of Small Peripheral Adenocarcinoma of the Lung
resolves10.1016/S0003-4975(01)02520-6
Nodal occult metastasis in patients with peripheral lung adenocarcinoma of 2.0 cm or less in diameter
resolves10.1097/JTO.0b013e318206a221
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
resolves10.1038/modpathol.3800780
A micropapillary pattern is predictive of a poor prognosis in lung adenocarcinoma, and reduced surfactant apoprotein A expression in the micropapillary pattern is an excellent indicator of a poor prognosis
resolves10.1097/00000478-200301000-00011
Early-Stage Lung Adenocarcinomas With a Micropapillary Pattern, a Distinct Pathologic Marker for a Significantly Poor Prognosis
resolves10.1097/00000478-200203000-00010
Micropapillary Component in Lung Adenocarcinoma
resolves10.1016/S0169-5002(03)00362-3
Patterns of recurrence of bronchioloalveolar cell carcinoma after surgical resection: a radiological, histological, and immunohistochemical study
resolves10.1002/(SICI)1096-9896(199607)179:3<254::AID-PATH589>3.0.CO;2-J
BRONCHIOLOALVEOLAR LUNG CARCINOMAS: K-ras MUTATIONS ARE CONSTANT EVENTS IN THE MUCINOUS SUBTYPE
resolves10.1002/path.1566
CK20 expression, CDX2 expression, <i>K</i> ‐ <i>ras</i> mutation, and goblet cell morphology in a subset of lung adenocarcinomas
resolves10.1309/550P-QLJX-D84W-F6DN
Mucinous and Nonmucinous Bronchioloalveolar Adenocarcinomas Have Distinct Staining Patterns With Thyroid Transcription Factor and Cytokeratin 20 Antibodies
resolves10.1007/s00408-009-9149-3
The Importance of Distinguishing Mucinous and Nonmucinous Bronchioloalveolar Carcinomas
resolves10.1016/j.lungcan.2008.11.009
Mucinous versus nonmucinous solitary pulmonary nodular bronchioloalveolar carcinoma: CT and FDG PET findings and pathologic comparisons
resolves10.1016/j.lungcan.2009.05.021
Non-mucinous and mucinous subtypes of adenocarcinoma with bronchioloalveolar carcinoma features differ by biomarker expression and in the response to gefitinib
resolves10.2353/jmoldx.2007.060182
Mucinous Differentiation Correlates with Absence of EGFR Mutation and Presence of KRAS Mutation in Lung Adenocarcinomas with Bronchioloalveolar Features
resolves10.1097/PAS.0b013e3181e4ee32
A Grading System of Lung Adenocarcinomas Based on Histologic Pattern is Predictive of Disease Recurrence in Stage I Tumors
resolves10.1097/JTO.0b013e31818e0d9f
Visceral Pleural Invasion: Pathologic Criteria and Use of Elastic Stains: Proposal for the 7th Edition of the TNM Classification for Lung Cancer
resolves10.1097/JTO.0b013e31812f3c1a
The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours
resolves10.1002/cncr.24831
Prognostic significance of grading in lung adenocarcinoma
resolves10.1016/j.athoracsur.2006.01.021
Prognostic Value of Histology in Resected Lung Cancer With Emphasis on the Relevance of the Adenocarcinoma Subtyping
resolves10.1016/j.lungcan.2009.04.014
Structural and biological properties of a papillary component generating a micropapillary component in lung adenocarcinoma
resolves10.1038/modpathol.2008.79
Histopathological features and prognostic significance of the micropapillary pattern in lung adenocarcinoma
resolves10.1038/modpathol.3800765
Micropapillary pattern and grade of stromal invasion in pT1 adenocarcinoma of the lung: usefulness as prognostic factors
resolves10.1111/j.1365-2559.2005.02126.x
Micropapillary pattern: a distinct pathological marker to subclassify tumours with a significantly poor prognosis within small peripheral lung adenocarcinoma (≤20 mm) with mixed bronchioloalveolar and invasive subtypes (Noguchi's type C tumours)
resolves10.1016/0003-4975(91)90847-J
Bronchoalveolar carcinoma: Factors affecting survival
resolves10.1002/1097-0142(19840801)54:3<525::AID-CNCR2820540324>3.0.CO;2-X
Bronchioloalveolar carcinoma: The significance of two histopathologic types
resolves10.1097/JTO.0b013e3181abeb5d
IFCT-0401 Trial: A Phase II Study of Gefitinib Administered as First-Line Treatment in Advanced Adenocarcinoma with Bronchioloalveolar Carcinoma Subtype
resolves10.3816/CLC.2008.n.004
Bronchioloalveolar Carcinoma: The Case for Two Diseases
resolves10.1002/1097-0142(19860415)57:8<1555::AID-CNCR2820570820>3.0.CO;2-N
Bronchioloalveolar carcinomas. Cell types, patterns of growth, and prognostic correlates
The 7 references without a DOI — listed, not checked
no DOI — not checked10.1038/modpathol.2010.232_bib1
no DOI — not checkedCohen PR, Yoshizawa A, Motoi N, et al. Signet ring cell features (SRCF) in lung adenocarcinoma: a cytologic feature or a histologic subtype? Mod Pathol 2010;23.
no DOI — not checkedDeshpande CG, Yoshizawa A, Motoi N, et al. Clear cell change in lung adenocarcinoma: a cytologic change rather than a histologic variant. Mod Pathol 2009;22.
no DOI — not checked10.1038/modpathol.2010.232_bib22
no DOI — not checkedLung
no DOI — not checked10.1038/modpathol.2010.232_bib26
no DOI — not checkedHayes DF, Allred C, Anderson BO, et al. Breast. In: Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds), AJCC Cancer Staging Manual, 7th edn, Springer: New York, 2009.
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-08-16 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1038/modpathol.2010.232"><img src="https://citestamp.com/citestamped/10.1038/modpathol.2010.232/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1038/modpathol.2010.232/badge.svg)](https://citestamp.com/citestamped/10.1038/modpathol.2010.232)